Developer docs
API playgroundTry for free, no card

Search company profiles

Sanyuan Bio

Full company profile

uuid0021bnd

Namestring
Sanyuan Bio
Legal namestring
山东三元生物科技股份有限公司
Websiteurl
bzsanyuan.com
Company typeenum
Public
Founded yearint
2007
Descriptiontext

Sanyuan Bio (山东三元生物科技股份有限公司) is a Chinese biotechnology manufacturer specializing in fermentation-based production of functional sugar substitutes. Founded in 2007 and headquartered in Binzhou, Shandong Province on a 330-acre industrial site, the company produces erythritol (135,000 tons annual capacity), D-allulose (10,000 tons, expanding to 20,000 tons), Rebaudioside M (>=95% purity), and compound sweetener blends. Its core technology is proprietary microbial fermentation with claimed high conversion rates and low energy consumption, backed by 31 national IP patents, 3 utility model patents, and an exclusive D-allulose enzyme arrangement with the CAS Tianjin Institute of Industrial Biotechnology. R&D is run through a Tianjin Free Trade Zone subsidiary ("Sanyuan Bioengineering Research (Tianjin) Co., Ltd.") integrating strain work, pilot testing, and industrialization.

The company operates a B2B ingredient model, selling sweetener inputs to food and beverage manufacturers, pharmaceutical companies, cosmetics/personal care brands, and health product companies. Domestically it runs two dedicated sales divisions managing accounts such as Jinmailang, Dali Foods, Heytea, and Perfect China. Internationally it holds self-operated import/export rights and distributes through partners including Faravelli (Italy), Prinova, and New Zealand International Chemical, reaching more than 40 countries with primary weighting toward Europe and the Americas. Certifications (ISO9001/14001/22000, BRC, FDA facility registration, KOSHER, HALAL, Non-GMO IP, SMETA) and four-ministry "National Key New Product" recognition are central to its enterprise customer-access moat.

Sanyuan Bio listed on the Shenzhen Stock Exchange ChiNext Board on February 10, 2022 (ticker 301206). Post-IPO it has been executing an aggressive capacity and portfolio expansion: a new erythritol line went into full operation in May 2023, a 50,000-ton erythritol project completed energy acceptance in July 2025, and a February 2025 RMB 200 million project converts a production line into an 85,000-ton flexible bio-synthetic platform capable of switching between erythritol, tagatose, mannitol, sorbitol, and steviol glycosides. Strategic positioning emphasizes synthetic biology, with chairman Nie Zaijian and chief scientist Ling Peixue publicly leading the company's industry positioning at SZSE and academic forums.

Short descriptiontext

Sanyuan Bio is a Chinese fermentation biotech manufacturer of erythritol (135,000-ton capacity), D-allulose, Rebaudioside M, and compound sweeteners, supplying food and beverage, pharmaceutical, and cosmetics ingredient customers across 40+ countries via B2B sales and international distribution partners.

Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersShandong, China
HQ citystring
Shandong
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fermented erythritol production, zero-calorie sweeteners, D-allulose manufacturing, Rebaudioside M stevia, compound sweetener blends
Industry3 codes
1Sweeteners (Sugar, HFCS, Alternative Sweeteners)
CodeCRADAOABPrimaryYes
2Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin)
CodeAFAJAAAHPrimaryNo
3Sweetener Blends & Systems (Bulk + HIS Blends, Customized Sweetening Systems)
CodeAFAJAAAOPrimaryNo
NAICS code1 code
  • Sugar and Confectionery Product Manufacturing3113
SIC code1 code
  • Sugar & Confectionery Products2060
Product category
Functional Sweetener Ingredients
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Erythritol Sales
TypeOne Time License
Description

Primary revenue stream from erythritol production and sales. The company has annual production capacity of 135,000 tons of erythritol. Products are sold in various forms including different mesh sizes (20-30, 30-60, 60-80, 100 mesh) and packaging options.

bzsanyuan.com
2Allulose (D-psicose) Sales
TypeOne Time License
Description

Revenue from allulose production with current capacity of 10,000 tons, with plans to expand to 20,000 tons in 2025. Available in both liquid and granular forms.

bzsanyuan.com
3Rebaudioside M (Stevia) Sales
TypeOne Time License
Description

Sales of high-purity Rebaudioside M (>=95%) used in beverages, baking, dairy, pharmaceuticals, and personal care products.

bzsanyuan.com
4Compound Sweetener Sales
TypeOne Time License
Description

Blended sweetener products combining erythritol with various high-intensity sweeteners (stevia, monk fruit extract, sucralose) and small packaging consumer products including table sweeteners and flavored solid beverages.

bzsanyuan.com
5Export Sales
TypeOne Time License
Description

International sales through self-operated import/export rights, with primary markets in Europe and America, and distribution across East Asia, Southeast Asia, Australia/New Zealand, and over 40 countries/regions.

bzsanyuan.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Infrastructure, Technology or R&D, Operations, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Sanyuan Bio manufactures zero- and low-calorie sweeteners using fermentation and synthetic biology methods, with a primary focus on erythritol (135,000 tons annual capacity) and D-allulose (10,000 tons, expanding to 20,000 tons in 2025). The company also produces Rebaudioside M stevia sweeteners and blended compound sweetener products for food, beverage, pharmaceutical, health product, and cosmetics manufacturers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Rebaudioside M sweetness reaches 350x sucrose with no aftertaste
+2 more records
Product and service5 records
1Erythritol (赤藓糖醇)
CategoryFunctional Sweetener Ingredients
Description

Zero-calorie bulk sweetener produced via fermentation, available in multiple mesh sizes (20-30, 30-60, 60-80, 100 mesh) and packaging options. Annual production capacity of 135,000 tons. Used in food, beverages, baked goods, pharmaceuticals, and personal care products.

2D-Allulose (D-阿洛酮糖)
CategoryFunctional Sweetener Ingredients
Description

Low-calorie sweetener with near-sucrose taste profile and energy of 1.67 kJ/g. Available in both liquid and granular forms. Current annual capacity of 10,000 tons, with plans to expand to 20,000 tons in 2025. Used in beverages, baking, dairy, and health products.

3Rebaudioside M (莱鲍迪苷M)
CategoryFunctional Sweetener Ingredients
Description

High-purity stevia sweetener (>=95%) developed via synthetic biology, delivering 350x sucrose sweetness without the aftertaste of ordinary stevia glycosides. Used in beverages, baking, dairy, pharmaceuticals, and personal care products.

4Compound Sweeteners (复配糖)
CategoryFunctional Sweetener Ingredients
Description

Blended sweetener products combining erythritol with various high-intensity sweeteners including stevia, monk fruit extract (罗汉果甜苷), and sucralose. Custom formulations available. Used in beverages, baked goods, and tabletop sweeteners.

5Small Package Consumer Sweeteners (小包装)
CategoryConsumer Sweetener Products
Description

Retail-sized erythritol and table sweetener products, including erythritol 500g bags and compound table sweeteners in 150g, 1kg bags, and 1.5kg gift boxes. Targeted at consumer end-users.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global agricultural processor with broad sweetener and natural-ingredient product lines; competes in food and beverage ingredient supply at scale across multiple geographies.

TypeBroad incumbent
Description

Established sweetener and food-ingredient producer with Splenda (sucralose) and stevia platforms plus specialty corn-derived ingredients; competes in zero/low-calorie sweetener B2B ingredient supply to global CPGs.

TypeBroad incumbent
Description

French starch- and polyol-derived ingredient manufacturer producing erythritol, sorbitol, mannitol, and specialty starches for food, nutrition, and pharma — directly competes in erythritol and rare-sugar polyols for B2B customers.

TypeBroad incumbent
Description

Global taste and nutrition ingredients company with a sweetener portfolio serving food and beverage manufacturers — comparable as a scaled B2B ingredient supplier across multiple sweetener categories.

TypeDirect peer
Description

Direct Chinese competitor producing D-allulose and fermentation-based functional sugars; shares the same synthetic biology approach, allulose enzyme IP origin (CAS Tianjin Institute), and B2B sweetener ingredient model targeting food and beverage manufacturers.

TypeDirect peer
Description

Specialist producer of high-purity stevia Rebaudioside M and other steviol glycosides — directly competes with Sanyuan Bio's Reb M offering targeting beverage, dairy, and food manufacturers.

TypeEmerging player
Description

US-based specialist in enzymatic production of rare sugars including D-allulose and tagatose — direct competitor in next-generation rare-sugar fermentation that overlaps with Sanyuan Bio's allulose/tagatose pipeline.

TypeRegional player
Description

Chinese fermentation-based ingredient and pharmaceutical-intermediate producer with adjacent stevia and functional sugar programs — comparable to Sanyuan Bio as a domestic Chinese competitor in fermentation-derived functional sweeteners.

TypeBroad incumbent
Description

Global food-ingredients incumbent offering erythritol, stevia, and other sweeteners across food, beverage, and nutrition categories — competes head-to-head in bulk sweetener supply with broader portfolio and Western distribution.

TypeBroad incumbent
Description

Global ingredient solutions provider with the PureCircle stevia franchise; competes in the same B2B high-intensity sweetener supply channel with extensive Western CPG distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sanyuan Bio

Functional Sweetener Ingredientsbzsanyuan.com

Sanyuan Bio is a Chinese fermentation biotech manufacturer of erythritol (135,000-ton capacity), D-allulose, Rebaudioside M, and compound sweeteners, supplying food and beverage, pharmaceutical, and cosmetics ingredient customers across 40+ countries via B2B sales and international distribution partners.

What Sanyuan Bio does

Sanyuan Bio (山东三元生物科技股份有限公司) is a Chinese biotechnology manufacturer specializing in fermentation-based production of functional sugar substitutes. Founded in 2007 and headquartered in Binzhou, Shandong Province on a 330-acre industrial site, the company produces erythritol (135,000 tons annual capacity), D-allulose (10,000 tons, expanding to 20,000 tons), Rebaudioside M (>=95% purity), and compound sweetener blends. Its core technology is proprietary microbial fermentation with claimed high conversion rates and low energy consumption, backed by 31 national IP patents, 3 utility model patents, and an exclusive D-allulose enzyme arrangement with the CAS Tianjin Institute of Industrial Biotechnology. R&D is run through a Tianjin Free Trade Zone subsidiary ("Sanyuan Bioengineering Research (Tianjin) Co., Ltd.") integrating strain work, pilot testing, and industrialization.

The company operates a B2B ingredient model, selling sweetener inputs to food and beverage manufacturers, pharmaceutical companies, cosmetics/personal care brands, and health product companies. Domestically it runs two dedicated sales divisions managing accounts such as Jinmailang, Dali Foods, Heytea, and Perfect China. Internationally it holds self-operated import/export rights and distributes through partners including Faravelli (Italy), Prinova, and New Zealand International Chemical, reaching more than 40 countries with primary weighting toward Europe and the Americas. Certifications (ISO9001/14001/22000, BRC, FDA facility registration, KOSHER, HALAL, Non-GMO IP, SMETA) and four-ministry "National Key New Product" recognition are central to its enterprise customer-access moat.

Sanyuan Bio listed on the Shenzhen Stock Exchange ChiNext Board on February 10, 2022 (ticker 301206). Post-IPO it has been executing an aggressive capacity and portfolio expansion: a new erythritol line went into full operation in May 2023, a 50,000-ton erythritol project completed energy acceptance in July 2025, and a February 2025 RMB 200 million project converts a production line into an 85,000-ton flexible bio-synthetic platform capable of switching between erythritol, tagatose, mannitol, sorbitol, and steviol glycosides. Strategic positioning emphasizes synthetic biology, with chairman Nie Zaijian and chief scientist Ling Peixue publicly leading the company's industry positioning at SZSE and academic forums.

Sanyuan Bio firmographics

Firmographics
Name
Sanyuan Bio
Legal name
山东三元生物科技股份有限公司
Website
https://bzsanyuan.com
Company type
Public
Founded year
2007
Headcount range
51–100 employees
Short description
Sanyuan Bio is a Chinese fermentation biotech manufacturer of erythritol (135,000-ton capacity), D-allulose, Rebaudioside M, and compound sweeteners, supplying food and beverage, pharmaceutical, and cosmetics ingredient customers across 40+ countries via B2B sales and international distribution partners.
Ownership category
akta.pro rank

Sanyuan Bio industry classification

Industry
Product category
Functional Sweetener Ingredients
NAICS
Sugar and Confectionery Product Manufacturing (3113)
SIC
Sugar & Confectionery Products (2060)
akta.pro primary industry
Sweeteners (Sugar, HFCS, Alternative Sweeteners) (CRADAOAB)
akta.pro secondary industries
Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin) (AFAJAAAH), Sweetener Blends & Systems (Bulk + HIS Blends, Customized Sweetening Systems) (AFAJAAAO)

Keywords

  • Fermented erythritol production
  • Zero-calorie sweeteners
  • D-allulose manufacturing
  • Rebaudioside M stevia
  • Compound sweetener blends

Where Sanyuan Bio is headquartered

Location

Headquarters

HQ city
Shandong
HQ country
China
HQ region
Asia

Offices2 records

Markets served

Sanyuan Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Infrastructure, Technology or R&D, Operations, Personnel

Revenue model

  1. Erythritol Sales: Primary revenue stream from erythritol production and sales. The company has annual production capacity of 135,000 tons of erythritol. Products are sold in various forms including different mesh sizes (20-30, 30-60, 60-80, 100 mesh) and packaging options.
  2. Allulose (D-psicose) Sales: Revenue from allulose production with current capacity of 10,000 tons, with plans to expand to 20,000 tons in 2025. Available in both liquid and granular forms.
  3. Rebaudioside M (Stevia) Sales: Sales of high-purity Rebaudioside M (>=95%) used in beverages, baking, dairy, pharmaceuticals, and personal care products.
  4. Compound Sweetener Sales: Blended sweetener products combining erythritol with various high-intensity sweeteners (stevia, monk fruit extract, sucralose) and small packaging consumer products including table sweeteners and flavored solid beverages.
  5. Export Sales: International sales through self-operated import/export rights, with primary markets in Europe and America, and distribution across East Asia, Southeast Asia, Australia/New Zealand, and over 40 countries/regions.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Sanyuan Bio product offering

Product offering

Core offering

Sanyuan Bio manufactures zero- and low-calorie sweeteners using fermentation and synthetic biology methods, with a primary focus on erythritol (135,000 tons annual capacity) and D-allulose (10,000 tons, expanding to 20,000 tons in 2025). The company also produces Rebaudioside M stevia sweeteners and blended compound sweetener products for food, beverage, pharmaceutical, health product, and cosmetics manufacturers globally.

Differentiator

Problem solved

Functional benefit

Products and services

  • Erythritol (赤藓糖醇) Zero-calorie bulk sweetener produced via fermentation, available in multiple mesh sizes (20-30, 30-60, 60-80, 100 mesh) and packaging options. Annual production capacity of 135,000 tons. Used in food, beverages, baked goods, pharmaceuticals, and personal care products.
  • D-Allulose (D-阿洛酮糖) Low-calorie sweetener with near-sucrose taste profile and energy of 1.67 kJ/g. Available in both liquid and granular forms. Current annual capacity of 10,000 tons, with plans to expand to 20,000 tons in 2025. Used in beverages, baking, dairy, and health products.
  • Rebaudioside M (莱鲍迪苷M) High-purity stevia sweetener (>=95%) developed via synthetic biology, delivering 350x sucrose sweetness without the aftertaste of ordinary stevia glycosides. Used in beverages, baking, dairy, pharmaceuticals, and personal care products.
  • Compound Sweeteners (复配糖) Blended sweetener products combining erythritol with various high-intensity sweeteners including stevia, monk fruit extract (罗汉果甜苷), and sucralose. Custom formulations available. Used in beverages, baked goods, and tabletop sweeteners.
  • Small Package Consumer Sweeteners (小包装) Retail-sized erythritol and table sweetener products, including erythritol 500g bags and compound table sweeteners in 150g, 1kg bags, and 1.5kg gift boxes. Targeted at consumer end-users.

Quantifiable outcome

  • Rebaudioside M sweetness reaches 350x sucrose with no aftertaste
  • +2 more outcomes

Companies that use Sanyuan Bio

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Sanyuan Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Sanyuan Bio partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves11 records

Expansion highlights3 records

Sanyuan Bio competitors and assessment

Company assessment

Broad incumbents

  • ADM: Global agricultural processor with broad sweetener and natural-ingredient product lines; competes in food and beverage ingredient supply at scale across multiple geographies.
  • Tate & Lyle: Established sweetener and food-ingredient producer with Splenda (sucralose) and stevia platforms plus specialty corn-derived ingredients; competes in zero/low-calorie sweetener B2B ingredient supply to global CPGs.
  • Roquette: French starch- and polyol-derived ingredient manufacturer producing erythritol, sorbitol, mannitol, and specialty starches for food, nutrition, and pharma — directly competes in erythritol and rare-sugar polyols for B2B customers.
  • Kerry Group: Global taste and nutrition ingredients company with a sweetener portfolio serving food and beverage manufacturers — comparable as a scaled B2B ingredient supplier across multiple sweetener categories.
  • Cargill: Global food-ingredients incumbent offering erythritol, stevia, and other sweeteners across food, beverage, and nutrition categories — competes head-to-head in bulk sweetener supply with broader portfolio and Western distribution.
  • Ingredion (incl. PureCircle): Global ingredient solutions provider with the PureCircle stevia franchise; competes in the same B2B high-intensity sweetener supply channel with extensive Western CPG distribution.

Direct peers

  • Shandong Fuyang Biotechnology: Direct Chinese competitor producing D-allulose and fermentation-based functional sugars; shares the same synthetic biology approach, allulose enzyme IP origin (CAS Tianjin Institute), and B2B sweetener ingredient model targeting food and beverage manufacturers.
  • SweeGen: Specialist producer of high-purity stevia Rebaudioside M and other steviol glycosides — directly competes with Sanyuan Bio's Reb M offering targeting beverage, dairy, and food manufacturers.

Emerging players

  • Bonumose: US-based specialist in enzymatic production of rare sugars including D-allulose and tagatose — direct competitor in next-generation rare-sugar fermentation that overlaps with Sanyuan Bio's allulose/tagatose pipeline.

Regional players

  • Zhucheng Haotian Pharmaceutical: Chinese fermentation-based ingredient and pharmaceutical-intermediate producer with adjacent stevia and functional sugar programs — comparable to Sanyuan Bio as a domestic Chinese competitor in fermentation-derived functional sweeteners.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Sanyuan Bio social profiles

Digital presence

Sanyuan Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sanyuan Bio leadership team

Management profile

Number of profiles

Profiles2 records

Sanyuan Bio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sanyuan Bio M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanyuan Bio

What does Sanyuan Bio do?

Sanyuan Bio manufactures zero- and low-calorie sweeteners using fermentation and synthetic biology methods, with a primary focus on erythritol (135,000 tons annual capacity) and D-allulose (10,000 tons, expanding to 20,000 tons in 2025). The company also produces Rebaudioside M stevia sweeteners and blended compound sweetener products for food, beverage, pharmaceutical, health product, and cosmetics manufacturers globally.

Is Sanyuan Bio a public or private company?

Sanyuan Bio is a public company. It is classified as public.

When was Sanyuan Bio founded?

Sanyuan Bio was founded in 2007. It employs 51 to 100 people.

Where is Sanyuan Bio based?

Sanyuan Bio is headquartered in Shandong, China, in the Asia region.

How does Sanyuan Bio make money?

Five revenue lines are on record. Erythritol Sales are the primary driver. The others are allulose (D-psicose) Sales, rebaudioside M (Stevia) Sales, compound Sweetener Sales and export Sales.

Who are Sanyuan Bio's main competitors?

Broad incumbents on record are ADM, Tate & Lyle, Roquette, Kerry Group, Cargill and Ingredion (incl. PureCircle). Direct peers are Shandong Fuyang Biotechnology and SweeGen. Bonumose is listed as an emerging player. Zhucheng Haotian Pharmaceutical is listed as a regional player.

Does Sanyuan Bio have an API?

No public API is recorded for Sanyuan Bio.

What industry is Sanyuan Bio in?

Sanyuan Bio's product category is Functional Sweetener Ingredients. Its primary akta.pro industry code is CRADAOAB, Sweeteners (Sugar, HFCS, Alternative Sweeteners), with a secondary code of AFAJAAAH, Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin). Its NAICS code is 3113 and its SIC code is 2060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals